Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Prevention and Control of Neoplasms Associated With HPV in High-risk Groups in Mexico City: The Condesa Study [Phase 2, Phase 3]
Phase 2/3 clinical trial update on prevention and control of cancers associated with HPV in high-risk groups in Mexico City (Condesa Study) …
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: AK105 Combined With Anlotinib in Patients With Cervical Cancer [Phase 2]
Phase 2 clinical trial exploring AK105 in combination with Anlotinib for cervical cancer.
-
CLINICAL_TRIALS withdrawal · 2021-11-17Clinical Trial Update: Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Versus Definitive Chemoradiotherapy [Phase 3]
A Phase 3 trial comparing pretherapeutic paraaortic lymphadenectomy versus definitive chemoradiotherapy in locally advanced cervical cancer …
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors [Phase 3]
Phase 3 trial update evaluating isotretinoin for safety and effectiveness in HIV-infected women with cervical tumors/dysplasia.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Trial of Tisotumab Vedotin in Cervical Cancer [Phase 2]
Phase 2 clinical trial of tisotumab vedotin in cervical cancer has completed and results were posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy [Phase 2]
Phase 2 trial of PM00104 (Zalypsis) in advanced/metastatic endometrial or cervical cancer previously treated with one line of chemotherapy w…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX) [NA]
A terminated feasibility study evaluating beta-adrenergic blockade in cervical cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: Immunogenicity and Safety Study of NBP615 in Healthy Female [Phase 1, Phase 2]
Phase 1/2 trial update on immunogenicity and safety of NBP615 in healthy female participants with completed status.
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer [Phase 2]
Phase 2 trial evaluating camrelizumab plus apatinib versus chemotherapy plus bevacizumab as first-line treatment for advanced cervical cance…
-
FDA approval · 2021-09-20FDA Approved: TIVDAK — Original Application (SEAGEN INC.)
FDA approves Tivdak (tisotumab vedotin) under an original Biologics License Application from Seagen. It is approved for adult patients with …
-
CLINICAL_TRIALS research · 2021-09-16Clinical Trial Update: Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden [Phase 4]
Phase 4 clinical trial updating on concomitant HPV vaccination and HPV screening in Sweden, investigating HPV infection, CIN 2/3, and cervic…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer [Phase 2]
Phase 2 clinical trial update on pembrolizumab with radiation and an immune modulatory cocktail in cervical and endometrial/uterine cancers …
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Pembrolizumab in Pre Neoplastic High Grade HPV-related Vulvar and Cervical Lesions [Phase 2]
Phase 2 trial evaluating pembrolizumab for pre-neoplastic high-grade HPV-related vulvar and cervical lesions; current status unknown.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer [Phase 2]
Phase 2 trial update evaluating carboplatin-paclitaxel-pembrolizumab as neoadjuvant therapy for locally advanced cervical cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Evaluate Efficacy of the Association Nimotuzumab(HR3) /Cisplatin-Vinorelbine on Patients With Cervical Carcinom [Phase 3]
Phase 3 trial evaluating nimotuzumab in combination with cisplatin-vinorelbine for cervical cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer [Phase 2]
Phase 2 study evaluating camrelizumab with concurrent chemoradiation for cervical cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) [Phase 2]
Phase 2 trial evaluating ATG 008 (dual mTORC1/2 inhibitor) or ATG-010 (selective exportin 1 inhibitor) in combination with chemotherapy for …
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer [Phase 2]
Phase 2 trial update evaluating toripalimab in combination with chemotherapy and bevacizumab as first-line treatment for advanced cervical c…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer [NA]
Clinical trial update for fluorine F18 EF5 PET/CT imaging in locally advanced or recurrent/metastatic cervical cancer; study terminated with…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer [Phase 3]
Phase 3 trial evaluating Flexitouch home maintenance therapy versus standard home maintenance therapy for lower-extremity lymphedema followi…
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer [Phase 2]
Phase 2 clinical trial update evaluating adjuvant chemotherapy and anti-PD-1 antibody in advanced stage cervical cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors [Phase 2]
Phase 2 study of TQ-B3525 tablets in gynecologic tumors with PIK3CA/PIK3R1/2 alterations (advanced endometrial, cervical, and ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium [Phase 2]
Phase 2 trial evaluating bevacizumab and rucaparib in recurrent cervical or endometrial cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer [Phase 2]
Phase 2 clinical trial investigating Niraparib with Brivanib or Toripalimab in cervical cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation [Phase 3]
Phase 3 trial comparing oral ondansetron to transdermal granisetron for cervical, endometrial, or vaginal cancer patients undergoing pelvic …